Saint-Gobain divests plastic parts business ‘Freeglass’
Saint-Gobain has completed the sale of its automotive exterior plastic parts manufacturing business ‘Freeglass GmbH & Co. KG’ to HF Opportunities GmbH, a subsidiary of Hannover Finance.
The company’s industrial plant is located in Schwarzheim, Germany, and has been developing and producing plastic polymer components since 1998. In 2023, the company had sales of nearly €20 million and employed approximately 120 people.
The transaction is part of Saint-Gobain’s ongoing business position optimization strategy and is in line with the “Growth & Impact” strategic plan.
2026-10-16
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Saint-Gobain Expands Its Construction Chemicals Operations in Indonesia
-
Saint-Gobain’s Triple Acquisition: The “Small but Sophisticated” Strategy Behind Low-Carbon Building Materials
-
Saint-Gobain Makes Construction Chemicals Acquisitions in Canada, Italy, and Peru
-
Saint-Gobain to acquire Mexican construction chemicals company Ovniver Group for $815 million
-
India Targets Fake Drug Packaging
-
EFSA Renews Authorisation of Inositol for Use in Fish and Crustacean Feed
-
Selling the Family Silver for a New Suit? Why Bohai Chemical’s Transformation Drama Got Canceled After Just Two Acts
-
EFSA Approves Cellulase from GM Aspergillus Niger with Low Allergy Risk
-
Canada Launches Re-Evaluation of Herbicide Iodosulfuron-Methyl-Sodium
-
India’s Pharma Cost Problem Gets Worse
Recommend Reading
-
UK Proposes Sharp Increase in MRL for Flubendiamide in Tea
-
Singapore Suspends Poultry Imports from Avian Flu-Affected Areas in Japan
-
EFSA Finds L-Cysteine Feed Additives Safe for All Animal Species
-
EFSA Confirms Safety of Triacylglycerol Lipase for Expanded Food Uses
-
Sichuan Unveils Revised List of 14 Qualified Chemical Parks in Major Industrial Realignment
-
FDA Warning Letters Put GMP Back in Focus
-
Natural Rubber Prices Fluctuated Downward in 2025, Bottom Support Exists in 2026 with a Slight Shift Upward in Price Focus
-
China’s EVA Market to Experience Volatile Decline in 2025, with Supply Intensifying in 2026 and Demand Remaining Stable but Weak
-
FDA Fast-Tracks U.S. Drug Manufacturing
-
Dichloromethane 2025 Review and 2026 Outlook — Carrying Forward, Stalemate Persists